A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma

被引：0
|
作者：
Satoshi Murahashi
Daisuke Takahari
Takeru Wakatsuki
Naoki Fukuda
Takashi Ichimura
Mariko Ogura
Masato Ozaka
Eiji Shinozaki
Izuma Nakayama
Tomohiro Matsushima
Hiroki Osumi
Keisho Chin
Kensei Yamaguchi
机构：
[1] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Ramucirumab; Monotherapy; Gastric Cancer; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：92 / 97
页数：5
相关论文
共 50 条
  • [31] Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma
    Hofheinz, Ralf-Dieter
    Lorenzen, Sylvie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (06) : 607 - 614
  • [32] Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy
    Goetze, Thorsten Oliver
    Stein, Alexander
    Lorenzen, Sylvie
    Habibzada, Timorshah
    Goekkurt, Eray
    Herhaus, Peter
    Loose, Maria
    Sookthai, Disorn
    Brulin, Tanita
    Ihrig, Kristina
    Pauligk, Claudia
    Al-Batran, Salah-Eddin
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (10) : 1726 - 1733
  • [33] PEMETREXED MONOTHERAPY FOR JAPANESE PATIENTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Sato, Akira
    Misumi, Yuki
    Kashizaki, Fumihiro
    Ishii, Mari
    Shimokawa, Tsuneo
    Hida, Naoya
    Okamoto, Hiroaki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1213 - S1214
  • [34] A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
    Hong, YS
    Song, SY
    Lee, SI
    Chung, HC
    Choi, SH
    Noh, SH
    Park, JN
    Han, JY
    Kang, JH
    Lee, KS
    Cho, JY
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1344 - 1347
  • [35] Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study
    Hayato Kawachi
    Motohiro Tamiya
    Kinnosuke Matsumoto
    Akihiro Tamiya
    Takafumi Yanase
    Satoshi Tanizaki
    Toru Kumagai
    Investigational New Drugs, 2022, 40 : 634 - 642
  • [36] Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study
    Kawachi, Hayato
    Tamiya, Motohiro
    Matsumoto, Kinnosuke
    Tamiya, Akihiro
    Yanase, Takafumi
    Tanizaki, Satoshi
    Kumagai, Toru
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (03) : 634 - 642
  • [37] Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
    Al-Batran, S. -E.
    Van Cutsem, E.
    Oh, S. C.
    Bodoky, G.
    Shimada, Y.
    Hironaka, S.
    Sugimoto, N.
    Lipatov, O. N.
    Kim, T. -Y.
    Cunningham, D.
    Rougier, P.
    Muro, K.
    Liepa, A. M.
    Chandrawansa, K.
    Emig, M.
    Ohtsu, A.
    Wilke, H.
    ANNALS OF ONCOLOGY, 2016, 27 (04) : 673 - 679
  • [38] Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review
    Zhang, Xiaotian
    Zhou, Li
    Zhou, Chan
    Shen, Lin
    ADVANCES IN THERAPY, 2024, 41 (06) : 2112 - 2132
  • [39] A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Honda, Kazunori
    Asahina, Hajime
    Tamura, Yosuke
    Hozak, Rebecca R.
    Gao, Ling
    Suzukawa, Kazumi
    Enatsu, Sotaro
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (04) : 298 - 305
  • [40] Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study
    Masuda, Norikazu
    Iwata, Hiroji
    Aogi, Kenjiro
    Xu, Yihuan
    Ibrahim, Ayman
    Gao, Ling
    Dalal, Rita
    Yoshikawa, Reigetsu
    Sasaki, Yasutsuna
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1088 - 1094
12345